Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Attention-Deficit/ Hyperactivity Disorder (ADHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02502799
What this trial is testing

Intervention for Teens With ADHD and Substance Use

Who this might be right for
Attention Deficit Hyperactivity Disorder
Florida International University 158
Post-approval studies (Phase 4)Study completedNCT00517504
What this trial is testing

Methylphenidate Study in Young Children With Developmental Disorders

Who this might be right for
Attention Deficit Hyperactivity Disorder
University of Arizona 48
Large-scale testing (Phase 3)Study completedNCT01201187
What this trial is testing

Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHD

Who this might be right for
Mental Disorders
Yuyu Pharma, Inc. 144
Not applicableStudy completedNCT03003286
What this trial is testing

Community Based Intervention for Children With ADHD and ASD

Who this might be right for
Autism Spectrum DisorderAttention Deficit-Hyperactivity DisorderExecutive Function
Lauren Kenworthy 148
Post-approval studies (Phase 4)Study completedNCT00254462
What this trial is testing

Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children

Who this might be right for
Attention Deficit Disorder With Hyperactivity
University of Nebraska 93
Large-scale testing (Phase 3)Study completedNCT00191295
What this trial is testing

Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 240
Post-approval studies (Phase 4)Study completedNCT00914095
What this trial is testing

Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)

Who this might be right for
Parkinson's DiseaseGait Disorders, NeurologicDementia
University Hospital, Lille 69
Not applicableStudy completedNCT00819429
What this trial is testing

Supplements and Social Skills Intervention Study

Who this might be right for
Conduct DisorderAttention Deficit Hyperactivity DisorderOppositional Defiant Disorder
National Healthcare Group, Singapore 282
Not applicableLooking for participantsNCT06194994
What this trial is testing

Emotion Regulation as a Moderator of Two Different Treatments for Children With ODD

Who this might be right for
Oppositional Defiant Disorder
University of Iceland 196
Post-approval studies (Phase 4)Ended earlyNCT00687609
What this trial is testing

Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE

Who this might be right for
Attention Deficit Hyperactivity DisorderCannabis Abuse
Eli Lilly and Company 7
Not applicableStudy completedNCT00163865
What this trial is testing

A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents

Who this might be right for
Mental DisordersAffective DisordersAnxiety Disorders+2 more
Bayside Health 71
Not applicableNot Yet RecruitingNCT07154732
What this trial is testing

Transcranial Photobiomodulation With Multiple Interventions in Children With Attention-Deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)
Qilu Hospital of Shandong University 54
Not applicableNot Yet RecruitingNCT07092787
What this trial is testing

Reducing Smartphone Overuse for Adolescents With Attention-Deficit Hyperactive Disorder

Who this might be right for
Attention Deficit Hyerpactivity DisorderSmartphone Addiction
Education University of Hong Kong 120
Not applicableUnknownNCT04378699
What this trial is testing

2 Neurofeedback Protocols in the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents

Who this might be right for
ADHD
Fondation Lenval 70
Not applicableStudy completedNCT05835336
What this trial is testing

A Novel, Non-pharmacological, Intervention for the Management of ADHD in Adolescents

Who this might be right for
ADHD
VIZO Specs Ltd 32
Not applicableStudy completedNCT02249299
What this trial is testing

Experimental Medicine in ADHD - Cannabinoids

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)
King's College London 30
Large-scale testing (Phase 3)Study completedNCT06359899
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD

Who this might be right for
ADHD
Shanghai Ark Biopharmaceutical Co., Ltd. 55
Not applicableStudy completedNCT03967509
What this trial is testing

Effectiveness of Behavioral Preschool Teacher Training for Externalizing

Who this might be right for
Attention Deficit and Disruptive Behavior DisordersProblem BehaviorAttention Deficit Disorder With Hyperactivity
Uppsala University 100
Testing effectiveness (Phase 2)Study completedNCT01939353
What this trial is testing

Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder

Who this might be right for
Adult ADHD
Otsuka Pharmaceutical Development & Commercialization, Inc. 45
Early research (Phase 1)Study completedNCT07001475
What this trial is testing

Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder

Who this might be right for
Borderline Personality DisorderAttention Deficit Hyperactivity Disorder
Boehringer Ingelheim 78
Next Page